We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK Health Cost Watchdog Smiles on Drugs for Cancer, Arthritis, Lung Disease
UK Health Cost Watchdog Smiles on Drugs for Cancer, Arthritis, Lung Disease
The UK’s National Institute for Health and Care Excellence has issued recommendations for NHS to reimburse the use of seven biologicals in treating severe rheumatoid arthritis, along with four new cancer treatments and a lung disease therapy.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor